Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012

Jing Wang; Cui He; Jenny H. Hsi; Xiaoqin Xu; Yong Liu; Jianmei He; Hua Ling; Ping Ding; Yi Tong; Xiaobai Zou; Quanhua Zhou; Lingjie Liao; Xia Wang; Yuhua Ruan; Yiming Shao; Hui Xing

doi:10.1371/journal.pone.0088305

Loading metrics

Open Access

Peer-reviewed

Research Article

Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012

Jing Wang ,

Contributed equally to this work with: Jing Wang, Cui He, Jenny H. Hsi

Affiliation State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
⨯
Cui He ,

Contributed equally to this work with: Jing Wang, Cui He, Jenny H. Hsi

Affiliation State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
⨯
Jenny H. Hsi ,

Contributed equally to this work with: Jing Wang, Cui He, Jenny H. Hsi

Affiliation State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
⨯
Xiaoqin Xu,

Affiliation Jiangsu Center for Disease Control and Prevention, Nanjing, China
⨯
Yong Liu,

Affiliation Guizhou Center for Disease Control and Prevention, Guiyang, China
⨯
Jianmei He,

Affiliation Hunan Center for Disease Control and Prevention, Changsha, China
⨯
Hua Ling,

Affiliation Chongqing Center for Disease Control and Prevention, Chongqing, China
⨯
Ping Ding,

Affiliation Jiangsu Center for Disease Control and Prevention, Nanjing, China
⨯
Yi Tong,

Affiliation Guizhou Center for Disease Control and Prevention, Guiyang, China
⨯
Xiaobai Zou,

Affiliation Hunan Center for Disease Control and Prevention, Changsha, China
⨯
Quanhua Zhou,

Affiliation Chongqing Center for Disease Control and Prevention, Chongqing, China
⨯
Lingjie Liao,

Affiliation State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
⨯
Xia Wang,

Affiliation State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
⨯
Yuhua Ruan,

Affiliation State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
⨯
Yiming Shao,

Affiliation State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
⨯
[ ... ],
Hui Xing

* E-mail: xingh@chinaaids.cn

Affiliation State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
⨯
[ view all ]
[ view less ]

Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012

Jing Wang,
Cui He,
Jenny H. Hsi,
Xiaoqin Xu,
Yong Liu,
Jianmei He,
Hua Ling,
Ping Ding,
Yi Tong,
Xiaobai Zou

Published: February 7, 2014
https://doi.org/10.1371/journal.pone.0088305

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Antiretrovirals
Is the Subject Area "Antiretrovirals" applicable to this article?

Thanks for your feedback.
Protease inhibitor therapy
Is the Subject Area "Protease inhibitor therapy" applicable to this article?

Thanks for your feedback.
Viral load
Is the Subject Area "Viral load" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Virus testing
Is the Subject Area "Virus testing" applicable to this article?

Thanks for your feedback.
Chinese people
Is the Subject Area "Chinese people" applicable to this article?

Thanks for your feedback.